RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jordan White

Hickory, NCNPI 1730804287

Payments from drug & device makers

$3,500in general payments, 2019–2025

Across 172 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$476
  • AbbVie$385
  • Alkermes, Inc.$350
  • Axsome Therapeutics, Inc.$216
  • Otsuka America Pharmaceutical, Inc.$215
  • plus $677 from 10 others

What the payments were for

  • Food & beverage$3,45399%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Supernus Pharmaceuticals, Inc.37$1,181
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)18$476
AbbVie40$385
Alkermes, Inc.16$350
Axsome Therapeutics, Inc.6$216
Otsuka America Pharmaceutical, Inc.12$215
Lundbeck LLC6$136
Idorsia Pharmaceuticals US Inc6$131
Corium, LLC12$79
Almatica Pharma LLC4$66
Tris Pharma Inc4$58
Ironshore Pharmaceuticals Inc.3$53
Johnson & Johnson2$50
Neurocrine Biosciences, Inc.2$46
Takeda Pharmaceuticals U.S.A., Inc.3$44
Neos Therapeutics, LP1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →